• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SAMURAI:使用可重复且集成的生物信息学流程对拷贝数变异进行浅层分析。

SAMURAI: shallow analysis of copy number alterations using a reproducible and integrated bioinformatics pipeline.

作者信息

Potente Sara, Boscarino Diego, Paladin Dino, Marchini Sergio, Beltrame Luca, Romualdi Chiara

机构信息

Department of Biology, University of Padova, Via U.Bassi 58/ B, 35131, Italy.

AB Analitica S.r.l., Via Svizzera, 16, 35127, Padova, Italy.

出版信息

Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf035.

DOI:10.1093/bib/bbaf035
PMID:39879385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11775468/
Abstract

Shallow whole-genome sequencing (sWGS) offers a cost-effective approach to detect copy number alterations (CNAs). However, there remains a gap for a standardized workflow specifically designed for sWGS analysis. To address this need, in this work we present SAMURAI, a bioinformatics pipeline specifically designed for analyzing CNAs from sWGS data in a standardized and reproducible manner. SAMURAI is built using established community standards, ensuring portability, scalability, and reproducibility. The pipeline features a modular design with independent blocks for data preprocessing, copy number analysis, and customized reporting. Users can select workflows tailored for either solid or liquid biopsy analysis (e.g. circulating tumor DNA), with specific tools integrated for each sample type. The final report generated by SAMURAI provides detailed results to facilitate data interpretation and potential downstream analyses. To demonstrate its robustness, SAMURAI was validated using simulated and real-world data sets. The pipeline achieved high concordance with ground truth data and maintained consistent performance across various scenarios. By promoting standardization and offering a versatile workflow, SAMURAI empowers researchers in diverse environments to reliably analyze CNAs from sWGS data. This, in turn, holds promise for advancements in precision medicine.

摘要

浅层全基因组测序(sWGS)提供了一种经济高效的方法来检测拷贝数变异(CNA)。然而,专门为sWGS分析设计的标准化工作流程仍存在空白。为满足这一需求,在本研究中我们提出了SAMURAI,这是一种专门设计用于以标准化和可重复方式分析sWGS数据中CNA的生物信息学流程。SAMURAI是使用既定的社区标准构建的,确保了可移植性、可扩展性和可重复性。该流程具有模块化设计,包含用于数据预处理、拷贝数分析和定制报告的独立模块。用户可以选择针对实体活检或液体活检分析(例如循环肿瘤DNA)量身定制的工作流程,并为每种样本类型集成了特定工具。SAMURAI生成的最终报告提供详细结果,以促进数据解释和潜在的下游分析。为证明其稳健性,SAMURAI使用模拟和真实数据集进行了验证。该流程与真实数据高度一致,并在各种情况下保持一致的性能。通过促进标准化并提供通用的工作流程,SAMURAI使不同环境中的研究人员能够可靠地分析sWGS数据中的CNA。这反过来有望推动精准医学的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/3ab330924ab1/bbaf035f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/4ab35e7e2ab0/bbaf035f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/5bc9cfe0c15f/bbaf035f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/ec3885965731/bbaf035f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/3ab330924ab1/bbaf035f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/4ab35e7e2ab0/bbaf035f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/5bc9cfe0c15f/bbaf035f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/ec3885965731/bbaf035f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba9/11775468/3ab330924ab1/bbaf035f4.jpg

相似文献

1
SAMURAI: shallow analysis of copy number alterations using a reproducible and integrated bioinformatics pipeline.SAMURAI:使用可重复且集成的生物信息学流程对拷贝数变异进行浅层分析。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf035.
2
Characterization of Somatically-Acquired Copy Number Alterations in Chronic Lymphocytic Leukaemia Using Shallow Whole Genome Sequencing.利用浅层全基因组测序对慢性淋巴细胞白血病体细胞获得性拷贝数改变进行表征
Methods Mol Biol. 2019;1881:327-353. doi: 10.1007/978-1-4939-8876-1_23.
3
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
4
Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.在低覆盖度癌症基因组中进行大规模和焦点拷贝数改变的层次式发现。
BMC Bioinformatics. 2020 Apr 16;21(1):147. doi: 10.1186/s12859-020-3480-3.
5
PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based Approach.从癌症患者的血浆中进行无 PCR 浅层全基因组测序以检测染色体拷贝数是对传统基于 PCR 方法的有效替代。
J Mol Diagn. 2021 Nov;23(11):1553-1563. doi: 10.1016/j.jmoldx.2021.08.008. Epub 2021 Aug 26.
6
Software Workflows and Infrastructures for Precision Oncology.精准肿瘤学的软件工作流程和基础设施。
Adv Exp Med Biol. 2022;1361:23-35. doi: 10.1007/978-3-030-91836-1_2.
7
MVP: a modular viromics pipeline to identify, filter, cluster, annotate, and bin viruses from metagenomes.MVP:一个模块化的病毒组学分析流程,用于从宏基因组中识别、过滤、聚类、注释和分类病毒。
mSystems. 2024 Oct 22;9(10):e0088824. doi: 10.1128/msystems.00888-24. Epub 2024 Oct 1.
8
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.通过对 LM-PCR 全基因组扩增产物进行低深度测序进行单细胞全基因组拷贝数分析的简化工作流程。
PLoS One. 2018 Mar 1;13(3):e0193689. doi: 10.1371/journal.pone.0193689. eCollection 2018.
9
Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients.对循环游离 DNA 进行浅层全基因组测序可在神经母细胞瘤患者中实现可靠的非侵入性拷贝数分析。
Clin Cancer Res. 2017 Oct 15;23(20):6305-6314. doi: 10.1158/1078-0432.CCR-17-0675. Epub 2017 Jul 14.
10
Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants.萨雷克:用于种系和体细胞变异的全基因组测序分析的便携式工作流程。
F1000Res. 2020 Jan 29;9:63. doi: 10.12688/f1000research.16665.2. eCollection 2020.

引用本文的文献

1
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257).循环游离DNA(cfDNA)、肿瘤比例和突变的基线水平及动态变化,以预测接受一线阿特珠单抗和化疗的小细胞肺癌(SCLC)患者的临床病程:一项假说生成研究(CATS/ML43257)
J Exp Clin Cancer Res. 2025 Jun 19;44(1):178. doi: 10.1186/s13046-025-03434-3.

本文引用的文献

1
Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp.使用fastp进行超快速单通道FASTQ数据预处理、质量控制和重复数据删除。
Imeta. 2023 May 8;2(2):e107. doi: 10.1002/imt2.107. eCollection 2023 May.
2
PRKDC-Mediated NHEJ May Play a Crucial Role in Aneuploidy of Chromosome 8-Driven Progression of Ovarian Cancer.PRKDC 介导的 NHEJ 可能在染色体 8 驱动的卵巢癌细胞非整倍体进展中起关键作用。
Int J Mol Sci. 2024 Apr 28;25(9):4825. doi: 10.3390/ijms25094825.
3
Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers.
游离 DNA 浅层全基因组测序检测晚期癌症肿瘤分数的方法验证。
J Mol Diagn. 2024 May;26(5):413-422. doi: 10.1016/j.jmoldx.2024.01.014. Epub 2024 Mar 13.
4
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer.巴氏涂片测试中的 DNA 基因组不稳定性分析为高级别浆液性卵巢癌的早期诊断提供了原理证明。
Sci Transl Med. 2023 Dec 6;15(725):eadi2556. doi: 10.1126/scitranslmed.adi2556.
5
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial.采用浅层全基因组测序方法检测 PAOLA-1/ENGOT-OV25 Ⅲ期临床试验中的同源重组缺陷。
Oncogene. 2023 Nov;42(48):3556-3563. doi: 10.1038/s41388-023-02839-8. Epub 2023 Nov 9.
6
Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence.广泛的ctDNA突变谱反映了高级别浆液性癌肿瘤,并揭示了复发时出现的新突变。
Transl Oncol. 2024 Jan;39:101814. doi: 10.1016/j.tranon.2023.101814. Epub 2023 Nov 2.
7
Shallow Whole-Genome Sequencing of Cell-Free DNA (cfDNA) Detects Epithelial Ovarian Cancer and Predicts Patient Prognosis.游离DNA(cfDNA)的浅层全基因组测序可检测上皮性卵巢癌并预测患者预后。
Cancers (Basel). 2023 Jan 15;15(2):530. doi: 10.3390/cancers15020530.
8
Liquid biopsy: current technology and clinical applications.液体活检:当前技术与临床应用。
J Hematol Oncol. 2022 Sep 12;15(1):131. doi: 10.1186/s13045-022-01351-y.
9
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis.Ⅰ期上皮性卵巢癌的拷贝数改变突出了与预后相关的三种基因组模式。
Eur J Cancer. 2022 Aug;171:85-95. doi: 10.1016/j.ejca.2022.05.005. Epub 2022 Jun 14.
10
A pan-cancer compendium of chromosomal instability.泛癌症染色体不稳定性综合纲要。
Nature. 2022 Jun;606(7916):976-983. doi: 10.1038/s41586-022-04789-9. Epub 2022 Jun 15.